Bayesian Capital Management, LP Moderna, Inc. Transaction History
Bayesian Capital Management, LP
- $600 Million
- Q2 2025
A detailed history of Bayesian Capital Management, LP transactions in Moderna, Inc. stock. As of the latest transaction made, Bayesian Capital Management, LP holds 41,900 shares of MRNA stock, worth $1.18 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
41,900Holding current value
$1.18 Million% of portfolio
0.19%Shares
12 transactions
Others Institutions Holding MRNA
# of Institutions
856Shares Held
266MCall Options Held
28.5MPut Options Held
34.9M-
Vanguard Group Inc Valley Forge, PA41.7MShares$1.17 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$719 Million0.07% of portfolio
-
Baillie Gifford & CO21.8MShares$615 Million0.44% of portfolio
-
State Street Corp Boston, MA17.3MShares$486 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA8.88MShares$250 Million0.02% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $11B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...